Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Urine and serum concentrations of inhaled and oral terbutaline

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. The Association Between Self-Rated Fitness and Cardiorespiratory Fitness in Adults

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Maximal Fat Oxidation is Related to Performance in an Ironman Triathlon

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Urine concentrations of repetitive doses of inhaled salbutamol

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Screening for autologous blood transfusions

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Chronic rhinosinusitis in COPD: A prevalent but unrecognized comorbidity impacting health related quality of life

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. International severe asthma registry (ISAR): protocol for a global registry

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Airway hyperresponsiveness to mannitol improves in both type 2 high and type 2 low asthma after specialist management

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The six-gene expression signature in whole sampled sputum provides clinically feasible inflammatory phenotyping of asthma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
We examined urine and serum concentrations after therapeutic use of single and repetitive doses of inhaled and supratherapeutic oral use of terbutaline. We compared the concentrations in 10 asthmatics and 10 healthy subjects in an open-label, cross-over study with 2 mg inhaled and 10 mg oral terbutaline on 2 study days. Further, 10 healthy subjects were administrated 1 mg inhaled terbutaline in 4 repetive doses with total 4 mg. Blood samples were collected at baseline and during 6 h after the first inhalations. Urine samples were collected at baseline and during 12 h after the first inhalations. Median (IQR) urine concentrations peaked in the period 0-4 h after inhalation with Cmax 472 (324) ng/mL in asthmatics and 661 (517) ng/mL in healthy subjects, and 4-8 h after oral use with Cmax 666 (877) ng/mL in asthmatic and 402 (663) ng/mL in healthy subjects. In conclusion we found no significant differences in urine and serum concentrations between asthmatic and healthy subjects. We compared urine and serum concentrations after therapeutic inhaled doses and supratherapeutic oral doses and observed significant statistical differences in both groups but found it impossible to distinguish between therapeutic and prohibited use based on doping tests with urine and blood samples.
OriginalsprogEngelsk
TidsskriftInternational Journal of Sports Medicine
Vol/bind33
Udgave nummer12
Sider (fra-til)1026-33
Antal sider8
ISSN0172-4622
DOI
StatusUdgivet - 2012

ID: 36829588